Fig. 3From: Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrenceKaplan–Meier analysis (censored at 15 years of follow-up) in the below the median age population (age < 61 years old; N = 76) for a disease-specific survival and b disease-free survival, both according to H3K27me3 expression using 85% cut-offBack to article page